First Allied Asset Management’s Gilead Sciences GILD Stock Holding History

First Allied Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,021	Closed	-$1.67M	–	44
2015 Q1	$1.67M	Buy	+17,021	New	+$1.73M	0.23%	102

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Allied Asset Management's GILD Position: Q2 2015 in Review

First Allied Asset Management sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 17,021 shares — an estimated $1.67M sold.

First Allied Asset Management first reported a position in GILD in Q1 2015 and held it in 1 quarter. The position peaked at $1.67M in Q1 2015. 1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

First Allied Asset Management reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
First Allied Asset Management sold 17,021 Gilead Sciences shares in Q2 2015, an estimated $1.67M.
First Allied Asset Management first reported a position in Gilead Sciences in Q1 2015 and held it in 1 quarter.
First Allied Asset Management's Gilead Sciences position peaked at $1.67M in Q1 2015.
1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on First Allied Asset Management's 13F filing for Q2 2015.